TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial.

David Cella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.